Page 227 - Vitamin D and Cancer

214 F.S.G. Cheung and J.K.V. Reichardt

28. Chouvet C, Vicard E, Devonec M et al (1986) 1, 25-Dihydroxyvitamin D3 inhibitory effect
on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem
24(1):373–376
29. Colston K, Colston MJ, Feldman D (1981) 1, 25-dihydroxyvitamin D3 and malignant
melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology
108(3):1083–1086
30. Cooper GM, Hausman RE (2004) The cell: a molecular approach, 3rd edn. Sinaeur, Sunderland
31. Cross HS, Pavelka M, Slavik J et al (1992) Growth control of human colon cancer cells by
vitamin D and calcium in vitro. J Natl Cancer Inst 84(17):1355–1357
32. de Gruijl FR, van Kranen HJ, Mullenders LH (2001) UV-induced DNA damage, repair,
mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 63(1–3):19–27
33. De Haes P, Garmyn M, Degreef H et al (2003) 1, 25-Dihydroxyvitamin D3 inhibits ultraviolet
B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human
keratinocytes. J Cell Biochem 89(4):663–673
34. De Haes P, Garmyn M, Verstuyf A et al (2005) 1, 25-Dihydroxyvitamin D3 and analogues
protect primary human keratinocytes against UVB-induced DNA damage. J Photochem
Photobiol B 78(2):141–148
35. De Haes P, Garmyn M, Verstuyf A et al (2004) Two 14-epi analogues of 1, 25-dihydroxyvi-
tamin D3 protect human keratinocytes against the effects of UVB. Arch Dermatol Res
295(12):527–534
36. de Vries E, Coebergh JW (2004) Cutaneous malignant melanoma in Europe. Eur J Cancer
40(16):2355–2366
37. Decraene D, Agostinis P, Pupe A et al (2001) Acute response of human skin to solar radia-
tion: regulation and function of the p53 protein. J Photochem Photobiol B 63(1–3):78–83
38. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential
for anticancer therapeutics. Nat Rev Cancer 7(9):684–700
39. Dixon KM, Deo SS, Norman AW et al (2007) In vivo relevance for photoprotection by the
vitamin D rapid response pathway. J Steroid Biochem Mol Biol 103(3–5):451–456
40. Dixon KM, Deo SS, Wong G et al (2005) Skin cancer prevention: a possible role of 1,
25dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol 97(1–2):137–143
41. Dlugosz A, Merlino G, Yuspa SH (2002) Progress in cutaneous cancer research. J Investig
Dermatol Symp Proc 7(1):17–26
42. Dusso A, Lopez-Hilker S, Rapp N et al (1988) Extra-renal production of calcitriol in chronic
renal failure. Kidney Int 34(3):368–375
43. Eelen G, Verlinden L, De Clercq P et al (2006) Vitamin D analogs and coactivators.
Anticancer Res 26(4A):2717–2721
44. Eisman JA, Martin TJ, MacIntyre I et al (1979) 1, 25-dihydroxyvitamin-D-receptor in breast
cancer cells. Lancet 2(8156–8157):1335–1336
45. Elsner P, Holzle E, Diepgen T et al (2007) Recommendation: daily sun protection in the
prevention of chronic UV-induced skin damage. J Dtsch Dermatol Ges 5(2):166–173
46. Elwood JM, Jopson J (1997) Melanoma and sun exposure: an overview of published studies.
Int J Cancer 73(2):198–203
47. English DR, Armstrong BK, Kricker A et al (1998) Demographic characteristics, pigmentary
and cutaneous risk factors for squamous cell carcinoma of the skin: a case-control study. Int
J Cancer 76(5):628–634
48. Fang Y, van Meurs JB, D’Alesio A et al (2005) Promoter and 3¢-untranslated-region haplo-
types in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study.
Am J Hum Genet 77(5):807–823
49. Feldman GF, Pike WJ (2005) Vitamin D, 2nd edn. Academic, San Diego
50. Food and Nutrition Board (1997) Dietary reference intakes for Ca, P, Mg, vitamin D and F.
National Academic Press, Wiahington, DC
51. Frampton RJ, Suva LJ, Eisman JA et al (1982) Presence of 1, 25-dihydroxyvitamin D3
receptors in established human cancer cell lines in culture. Cancer Res 42(3):1116–1119